Back to Search
Start Over
O11-5 Durvalumab(D) ± tremelimumab(T) + platinum-etoposide(EP) in 1L ES-SCLC: Characterization of long-term benefit in CASPIAN.
- Source :
-
Annals of Oncology . 2021 Supplement 3, Vol. 32, pS289-S289. 1p. - Publication Year :
- 2021
- Subjects :
- *LUNG cancer treatment
*ETOPOSIDE
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152687067
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.05.537